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ABSTRACT 
IMPACT OF FAAH GENOTYPE AND MARIJUANA USE ON BRAIN STRUCTURE 
AND NEUROPSYCHOLOGICAL PERFORMANCE IN EMERGING ADULTS 
by 
Skyler G. Shollenbarger 
 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Professor Krista Lisdahl, Ph.D. 
 
Introduction: Chronic MJ use may be associated with higher cognitive ability 
impairments (see Lisdahl et al., 2013). Regions undergoing later maturation (Gogtay 
2004), may be at increased risk for MJ-induced alterations. Endogenous cannabinoid 
signaling (ECS) is modulated by the function the enzyme Fatty Acid Amide Hydrolase 
(see Ho & Hilard, 2005), thus the gene encoding for this enzyme (FAAH) impacts ECS 
(Sipe et al., 2002). Here, we examine the impact of MJ use and FAAH genotype on PFC 
complexity and underlying frontal white matter (WM) integrity in young adults. 
Methods: Participants included 37 MJ users and 37 non-using young adults (ages 18-25). 
Of those, 27 were FAAH A carriers and 47 were homozygous (C/C) carriers. Exclusion 
criteria included co-morbid psychiatric and neurologic disorders and excessive other drug 
use. Brain complexity and WM integrity was measured using local gyrification index and 
Tracula programs. The Letter Number Sequencing, PASAT and D-Kefs c/w interference 
measured complex attention and inhibition. Multiple regressions and Pearson r 
correlations were used to predict LGI, WM integrity and cognitive performance indices 
from MJ use status, FAAH status, and MJ*FAAH interactions controlling for 
demographic variables and comorbid drug use.  Results: MJ users demonstrated 
decreased LGI in bilateral vmPFC (RH: [beta=-.54, p<.001] and LH: [beta=-.55, 
p<.001]); bilateral mPFC (RH: [beta=-.48, p=.001] and LH: [beta=-.51, p<.001]); and 
bilateral frontal poles (RH: [beta=-.31, p=.02]; LH: [beta=-.43, p=.004]), with increased 
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LGI in LH DLPFC [beta=.40, p=.004]. Controlling for the same variables, reduced WM 
integrity was found in bilateral UCF (RH: [beta=.32, p=.03] and LH: [beta=.31, p=.03]) 
and fMinor [beta=.27, p=.05] tracts of MJ users. Significant interactions between 
MJ*FAAH were seen predicting LGI in LH OFC [beta=-.24, p=.04] and WM integrity in 
fMinor [beta=.26, p=.04] and LH ATR [beta=.36, p=.003]. In MJ users, increased 
gyrification was associated with better LNS performance in RH mPFC [r=.51, p=.001], 
RH vmPFC [r=.41, p=.01], and RH frontal pole [r=.45, p=.005] and a negative 
correlation with gyrification and color-word completion time in LH vmPFC [r=-.32, 
p=.05]. In MJ users, decreased WM integrity was associated with greater PASAT 
performance in the RH UNC [r=.38, p=.02]. Discussion: MJ use was associated with 
reduced LGI in several PFC regions with one region showing an opposite relationship. 
These results are consistent with Mata and colleagues (2010). We also found reduced 
WM integrity in fronto-temporal tracts, which may have important emotion regulation 
implications. These brain characteristics were also moderated by FAAH genotype. 
Additional implications of ECS and brain health will be discussed.  
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I. INTRODUCTION 
SIGNIFICANCE  
 Marijuana (MJ) use continues to be on the rise among youth populations, with up 
to 25% of adolescents reporting annual use, a nearly 4% significant increase from 2007 
(Johnston, O’Malley, Bachman, 2011a). Additionally, over one third of college students 
reported past year use (Johnston, O'Malley, Bachman & Schulenberg, 2011b) and in 
young adults aged 21-22 almost 20% reported past month use with roughly 6% reporting 
daily use in 2012 (Johnston, O’Malley, Bachman, Schulenberg, 2013). Among chronic 
MJ-using youth, evidence suggests impairments in higher order cognition, such as 
complex attention and working memory (Harvey, Sellman, Porter, & Frampton, 2007; 
Hanson et al., 2010; Medina et al., 2007; Lisdahl & Price, 2012).  
The central active ingredient in MJ, Δ 9- tetrahydrocannabinol (THC), binds to 
cannabinoid receptors (CB1) in the brain. In-vivo human research indicates the presence 
of CB1 receptors in several cortical regions, including the hippocampus and cerebellum, 
with increased densities in the prefrontal cortex (PFC) (Terry et al., 2009), a region 
associated with attention and executive functions (see Goldberg, 2009; see Yurgelun-
Todd, 2007). The CB1 receptor is part of a neurotransmitter system that responds to 
cannabinoids and this signaling, known as endocannabinoid signaling (ECS), is what 
causes the subjective experience of MJ use through retrograde regulation of monoamines, 
including dopamine (DA) (see Katona & Freund, 2012). Given that such processes may 
have an influence on addiction risk (Koob & Volkow, 2010) and executive functioning 
(EF) performance (for review see Egerton, Allison & Brett, 2006), it is plausible that 
variability in MJ-related neurocognitive consequences may be mediated by genes that 
  
 
2 
regulate ECS. One such candidate is fatty acid amide hydrolase (FAAH). To date, no 
studies have examined the impact of FAAH genotype on structural brain changes 
associated with adolescent and emerging adult MJ exposure. Consequently, there is great 
incentive to further understand the effects MJ has on the emerging adult brain. 
NEUROCHEMISTRY  
 Endogenous cannabinoids are produced naturally in the brain and exogenous MJ 
administration mimics the typical chemical function. In reaction to calcium build-up in 
the post synaptic cell, endogenous cannabinoids (e.g. N-arachidonylethanolamide or 
AEA) indirectly affect glutamate (GLU) and γ-Aminobutyric acid (GABA) release by 
binding to G-protein coupled CB1 receptors in pre-synaptic neurons (Gomez-Ruiz, 
Hernandez & Ramos, 2007; Howlett et al., 2004; Iversen, 2003; Kogan & Mechoulam, 
2006). FAAH inactivates and degrades AEA into two elements arachidonic acid and 
ethanolamine, which prevents AEA from activating the CB1 receptor (McKinney & 
Cravatt, 2005; Ho & Hillard, 2005). During MJ use, THC also binds to CB1 receptors and 
similarly affects GLU and GABA release (Iverson, 2003). This has both excitatory 
(decrease in GABA) and inhibitory (decrease in GLU) effects on the post-synaptic 
neurons, including other monoamines (Szabo & Schlicker, 2005), which may induce 
behavioral consequences. Throughout adolescence, neurochemical changes in AEA 
regulation occur through increasing reliance on the action of FAAH in regions within the 
PFC (Long, Lind, Webster & Weickert, 2012).  Additionally, chronic MJ using adults 
(ages 20-36) demonstrate significant, though reversible downregulation of CB1 receptors 
in the PFC (Hirvonen et al., 2012). Thus, a continuum of FAAH activity may have 
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unique structural implications for adolescent and emerging adult MJ users, particularly in 
areas such as the PFC.  
FAAH GENOTYPE AND ENDOCANNABINOID SIGNALING  
 Several genes contributing to individual variation in neurochemical responses 
may mediate ECS (Onaivi et al., 2002); recent data also suggest environmental influences 
on ECS response, specifically via unique fluctuations of endocannabinoids (Hill et al., 
2010). Though CB1 activation via AEA may be inhibited through AEA transport or 
FAAH activity, the latter was found to be the preferential constituent in the rat brain 
(Solinas et al., 2007). As previously mentioned, a potential biomarker of ECS is the gene 
encoding for the enzyme FAAH (FAAH; note: gene encoding for the FAAH enzyme is 
also called FAAH –all references to the gene will be FAAH) located on chromosome 
1p35-34 in humans. Specifically, a single nucleotide polymorphism (SNP) from C to A at 
position 385 (rs324420) in the human FAAH gene results in a conversion of amino acid 
proline to threonine (P129T), which renders the enzyme instable as evidenced in immune 
cell examination (Sipe et al., 2002; Chiang, Gerber, Sipe, & Cravatt, 2004). 
Consequently, the three most common genotypes are as follows: C/C (63.19%), C/A 
(30.56%), A/A (6.25%), and those carrying the rare nucleotide ‘A’ demonstrate elevated 
levels of AEA in blood plasma levels (Sipe et al., 2010). 
ECS has an important role in fetal and postnatal development, and FAAH activity 
is an important mediator in ECS regulation (Glaser et al., 2003; McFarland, Rakhshan, 
Wilson & Barker, 2004; Fernández-Ruiz, Berrendero, Hernández, Romero & Ramos 
1999; Fride, 2008; Harkany, Keimpema, Barabás & Mulder, 2008). Maturational 
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disruption, as evidenced in animal models (Bernard et al., 2005), may negatively impact 
network activity.  
ADOLESCENCE A SENSITIVE NEURODEVELOPMENTAL PERIOD? 
  In addition to ongoing development of the endocannabinoid system, there are also 
substantial neurodevelopmental changes present during adolescence through emerging 
adulthood, especially in the PFC (see Gogtay & Thompson, 2010; Gogtay et al., 2004). 
Underlying microstructural analysis demonstrate gray matter pruning in the PFC 
coincides with white matter (WM) tract development into early adulthood (Bava et al., 
2010), producing increased axonal insulation. Dynamic changes in reward centers predate 
maturation in the PFC (Casey, Jones & Hare, 2008; Ernst, Pine & Harden, 2006; Galvan 
et al., 2006), suggesting fewer resources available for top-down executive control and 
heightened impulsivity behaviors (Kelley et al., 2004), including initiation of MJ and 
other drug use during adolescence (Bava & Tapert, 2010). Animal and human studies 
investigating the impact of adolescent MJ use suggests marked changes in cognition, 
structure and neural recruitment (Jager & Ramsey, 2008), as well as neuropsychological 
decline (Meier et al., 2012). Adolescents also demonstrate pronounced vulnerability to 
MJ exposure (see Trezza, Cuomo & Vanderschuren, 2008), thus determining the 
influence of MJ use on regions undergoing neural maturation is necessary.  
  In addition to gray matter pruning, underlying maturation also occurs in WM with 
changes in both volumetric and cohesiveness of axons (Giedd, 2004; Lenroot & Giedd, 
2006; Schmithorst, Wilke, Dardzinski & Holland, 2002; Barnea-Goraly et al., 2005). 
Diffusion tensor imaging (DTI) provides in-vivo analysis of WM integrity through 
examining diffusion of water molecules. Quantification can be made on the direction, 
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which can be isotropic or anisotropic (fractional anisotropy; FA), and magnitude of 
diffusion (mean diffusivity; MD), and can be influenced by the geometric dimensions of 
the tissue (Beaulieu, 2002; Mamata et al., 2002; Pierpaoli, Jezzard, Basser, Barnett & Di 
Chiro, 1996). FA values range from 0-1,with greater values representing highly organized 
and cohesive tissue. Typically developing WM tracts demonstrate an inverse relationship 
between FA and MD. For example, during late adolescence and early adulthood WM 
cohesion increases, which causes increases in FA and decreases in MD within the PFC 
(Qiu, Li, Liu, Xie, & Wang, 2010) to support cognitive performance and guide 
increasingly complex behavior as we age (see Giedd, 2008; Bava et al., 2010). Increases 
in both FA and WM volume have been observed in healthy adolescent and emerging 
adults samples, particularly in PFC regions, which were associated with enhanced 
cognitive and intellectual abilities (Barnea-Goraly et al., 2005; Bava et al., 2010; Tamnes 
et al., 2011).  
  Functional neuroimaging studies found increased brain activation abnormalities in 
early-onset versus late-onset marijuana users (Becker, Wagner, Gouzoulis-Mayfrank, 
Spuentrup & Daumann, 2010; Gruber, Dahlgren, Sagar, Gönenc & Killgore 2012; Jager, 
Block, Lulten & Rarnsey, 2010). With critical changes in brain maturation occurring, 
human research must address MJ-induced cognitive and structural changes, particularly 
in later developing regions such as the PFC (Barnea-Goraly et al., 2005; Bava et al., 
2010; Gogtay et al., 2004).   
MARIJUANA COGNITIVE IMPACT IN ADOLECENTS AND EMERGING ADULTS 
 When examining neurocognition as it relates to MJ exposure, length of abstinence 
may impact behavior, especially for the chronic users, given traceable metabolites can be 
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detected 27 days following past use (Ellies, Mann, Judson, Schramm & Tashchian, 
1985). Though there is no evidence that metabolites can impact behavior, this aligns with 
subjective withdrawal symptoms persisting up to 28 days following abstinence (Kouri & 
Pope, 2000).  
 Studies requiring between 7 and 28 days of abstinence have found significantly 
slower processing speed, poorer complex attention, and cognitive inhibition (Lisdahl & 
Price, 2012); verbal memory, planning and sequencing ability (Medina et al., 2007); 
memory (Bartholomew, Holroyd & Heffernan, 2010); attention/executive performance 
(Tapert, Baratta, Abrantes & Brown, 2002); perseverative errors in problem-solving 
(Lane et al., 2007), and altered decision-making (Whitlow et al., 2004). In a non-
abstinent group of poly-substance using teens, neuropsychological performance was not 
associated with MJ use, though the group was also diagnosed with conduct disorder 
(Teichner, Donohue, Crum, Azrin & Golden, 2000). Despite the impairments listed 
above, functional neuroimaging studies suggest adolescent MJ use may cause heightened 
activation of PFC regions while completing spatial working memory (Schweinsburg et 
al., 2010), executive attention (Abdullaev et al., 2010), and inhibitory processing (Tapert 
et al., 2007) tasks. 
 In general, chronic MJ use appears to negatively impact behavioral (Fergusson et 
al., 2003; Iversen, 2005) and cognitive functioning (see Schweinsburg, Brown & Tapert, 
2008, see Lisdahl et al., 2012); though, neuropsychological impairments may be 
dependent upon initiation age of first usage (Ehrenreich et al., 1999; Huestegge et al., 
2002; Pope et al., 2003; Fontes et al., 2011; Solowij et al., 2012; Meier et al., 2012), and 
gender (Pope, Jacobs, Mialet, Yurgelun-Todd & Gruber, 1997; Lisdahl & Price, 2012). 
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Indeed, preliminary evidence suggests some deficits may be reversible following a 
discontinuation of use (Fried, Watkinson & Gray, 2005; Hanson et al., 2010; Tait, 
Mackinnon & Christensen, 2011).  
MARIJUANA STRUCTURAL CONSEQUENCES IN ADOLESCENCE 
 As the neocortex continues to mature throughout adolescence and emerging 
adulthood (Gogtay & Thompson, 2010; Gogtay et al., 2004), research highlighting the 
effects of MJ use on neural architecture has indicated abnormalities in regional gray 
matter volumes subserving memory and executive functioning, such as bilateral 
hippocampus, right amygdala, cerebellum and PFC regions (Cousijn et al., 2012; 
McQueeny et al., 2011; Medina, Nagel & Tapert, 2010; Medina et al., 2009). In light of 
the scope of this paper, structural consequences will focus on PFC and underlying PFC 
WM disparities between controls and MJ using emerging adults.   
PREFRONTAL CORTEX – STRUCTURAL FINDINGS 
 Animal models offer evidence for heightened PFC vulnerability to MJ exposure in 
adolescents (Ellgren et al., 2008). In humans, structural imaging studies also suggest that 
MJ use may impact typical neurodevelopment, particularly in later developing regions. 
For example, MJ users did not differ from controls in total PFC volume, although a 
marginal gender by group interaction was observed. Female MJ users demonstrated 
larger posterior PFC volumes, including the orbitofrontal cortex, than same-gendered 
controls and smaller PFC volume was associated with better performance (Medina et al., 
2009). In a group of heavy MJ-using adolescents reduced cortical thickness was found 
within frontal regions (Lopez-Larson et al., 2011), with age of onset negatively correlated 
with the right superior frontal gyrus. Additionally, another study found reduced medial 
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orbital frontal volume (mOFC) (Churchwell, Lopez-Larson, Yurgelun-Todd, 2010) in 
adolescent MJ-users. Our lab has also confirmed reductions in the mOFC as well as 
inferior parietal lobe in young adult MJ-users (Price et al., under review). Extensive 
exclusion criteria were implemented for these studies, suggesting that chronic MJ use in 
otherwise healthy youth can impact the structure and maturation processes of gray matter. 
Additional PFC characteristics aside from volume or cortical thickness, such as 
gyrification indices, may serve to elucidate the impact of MJ use on cortical changes.  
PREFRONTAL CORTEX- WHITE MATTER FINDINGS 
 Containing both myelin and oligodendrocytes, WM is responsible for efficient 
communication between different cortical regions and demonstrates a functional role in 
orchestrating brain networks (see Fields, 2008; see Fields & Stevens-Graham, 2002). Of 
note, CB1-rs are typically located on axons (see Mackie, 2005) although oligodendrocytes 
have also been found to contain CB1 receptors in the rat brain (Molina-Holgado et al., 
2002; Moldrich & Wenger, 2000), suggesting that cannabinoids may impact myelination. 
Further, adult animal studies examining repeated exposure to cannabinoid agonists found 
enhanced remyelination regulated through CB1 activation and agonist treatment may 
reduce oligodendrocyte progenitor apoptosis (i.e. programmed cellular death; Sun et al., 
2013; Molina-Holgado et al., 2002). Nonetheless, CB1 agonist exposure during 
adolescence may not parallel adult findings.   
Given continued PFC development (see Toga, Thompson & Sowell, 2006), with 
increased CB1 receptor density localized within the PFC (Terry et al., 2009), MJ-induced 
changes in WM may be heightened during this sensitive period. With once exception 
(DeLisi et al., 2006, see below), converging lines of evidence suggest that chronic MJ use 
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during adolescence results in reduced WM integrity in the corpus collosum (CC) (Arnone 
et al., 2008; Abou-Saleh, 2010; Zalesky et al., 2012), front-temporal tracts (Ashtari, 
Cervellione, Cottone, Ardekani & Kumra, 2009), and other PFC regions (Bava et al., 
2009; Yücel et al., 2010; Clark, Chung, Thatcher, Pajtek & Long, 2012). These WM 
differences have been linked with negative cognitive performance or behavioral 
outcomes in adolescent users (Bava, Jacobus, Mahmood, Yang & Tapert, 2010; Medina, 
Nagel, Park, McQueeny & Tapert, 2007). While current less infrequent use (i.e. not 
current regular users but used either 2-3 times to daily > 1 year during adolescence) in 
young adults aged 17-30 has been associated with increased FA/integrity compared to 
non-users (DeLisi et al., 2006), there are concerns regarding methodological limitations 
(e.g. comorbid drug/alcohol use, neurological insult history, handedness etc.), thus 
confounding variables may have driven the results. In summary, there is evidence of 
dynamic alterations in PFC microstructure are being reflected in MJ using adolescents 
and emerging adults, suggestive of heightened infrastructural vulnerabilities in early 
commencing users. Taking into consideration the later myelination of the PFC  (Bava et 
al., 2010) and discovery of CB1 receptors on myelinating glial cells (Molina-Holgado et 
al., 2002; Moldrich & Wenger, 2000), WM may prove to be more interactive with ones’ 
environment and reflect dynamic structural changes concomitant with our behavior 
(Ullén, 2009).  
CORTICAL GEOMETRY  
 Cortical folding (gyrification) patterns may be quantified and serve as another 
method to examine surface-based dimensions that reflect underlying organization (Schaer 
et al., 2008; 2012). Whether gyrification results from tensions propagated by amount of 
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connectivity and tension of WM (Van Essen, 1997) or differential cortical expansion 
(Richman et al., 1975; Ronan et al., 2013), cortical surface complexity increases between 
ages 6-16 in typically developing youth, most especially within the PFC (Blanton et al., 
2001). Evidence suggests increased gyrification may be associated with enhanced 
vocabulary in typically developing youth (Wallace et al., 2013).  To our knowledge, no 
studies to date have examined local gyrfication in adolescent MJ users.  
 Mata and colleagues (2010) examined cortical curvature, a similar measure to 
gyrification, in young adults (mean age of 25.7). MJ users demonstrated significant 
decreases in sulcal concavity compared to controls in regions of the frontal lobe, with 
significant reductions found in sulci thickness of the right frontal lobe in users (Mata et 
al., 2010). Given that global cortical comparisons were not found to be distinct between 
groups, the authors suggested sulcal curvature may be dependent upon WM tensions 
(Mata et al., 2010; Van Essen, 1997). As such, there is a need to examine PFC WM 
integrity among MJ-using adolescents and emerging adults.  
FAAH & MJ USE 
 Initial evidence suggests FAAH genotype may indeed moderate the effects of MJ 
use in youth. In young adult daily MJ users (ages 18-25), those with C/C genotype 
reported significantly increased craving (Haughey, Marshall, Schacht, Louis & 
Hutchison, 2008), and increased withdrawal symptoms and happiness following use 
(Schatch, Selling & Hutchinson, 2009). Adults with FAAH A/A genotype have 
demonstrated significantly reduced risk for developing MJ dependence compared to C/C 
or C/A carriers (Tyndale, Payne, Gerber & Sipe, 2007) and failed to demonstrate an 
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association with methamphetamine dependence (Morita et al., 2005), alcoholism (Iwasaki 
et al., 2007), or heroin (Proudnikov et al., 2010).  
Neuroimaging research has focused on adults and is mixed with regard to 
genotype and limbic reactivity. FAAH C/C genotype has been linked to increased reward 
sensitivity (Filbey et al., 2010), while other studies have found non-substance using adult 
A carriers to have heightened startle activation (Conzelmann et al., 2012) and increases in 
reward activation coupled with decreased threat-related reactivity (Hariri et al., 2009) Of 
note, Hariri and colleagues (2009) did not exclude for current substance use, which may 
impact functional activation patterns (Gruber & Yurgelun-Todd, 2005; Yurgelun-Todd et 
al. 1998) and Conzelmann and colleagues (2012) did not confirm abstinence with 
objective measures and relied on self-report. Thus far, preliminary research suggests a 
functional relationship with FAAH polymorphism and behavioral phenotypes, which 
necessitates the need to examine PFC structural differences between genotypes.  
AIMS & HYPOTHESES  
 The current study examined whether the FAAH gene or MJ use independently or 
interactively predict PFC cortical gyrification (Schaer et al., 2012) and underlying WM 
integrity (via FreeSurfer; Desikan et al., 2006; Yendiki et al., 2011) (see Figure 1). 
Further, the study will examine whether relationships exist between executive 
functioning (EF) and gray matter gyrification or WM regions that significantly differ 
between MJ users and controls (see Figure 2) in 18 to 25-year old healthy young adults 
without comorbid psychiatric or neurologic disorders.  
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---------------------------------- 
Insert Figures 1 & 2 Here 
---------------------------------- 
 Primary Aim 1: To examine the independent and interactive effects of MJ group 
status and FAAH genotype on dimensions of PFC gyrification.  
 Hypothesis 1. MJ users (based on previous findings; Mata et al., 2010) will have 
reduced gyrification compared to controls. Due to potential risk in MJ-using youth 
(Haughey et al., 2008; Schatch et al., 2009), individuals homozygous for C/C FAAH 
allele will have significantly less gyrification compared to A carriers. Further, MJ users 
that are C/C carriers of FAAH will demonstrate the least curvature in the PFC compared 
to MJ-using A allele carriers.  
Primary Aim 2: To examine the independent and interactive effects of MJ group 
status and FAAH genotype on WM integrity in the PFC. 
 Hypothesis 2. MJ users will have significantly poorer WM integrity (increased 
MD or decreased FA values) in the PFC compared to controls. Individuals with the C/C 
FAAH allele will have significantly poorer WM integrity in the PFC compared to A allele 
carriers. MJ users with the C/C FAAH allele will have significantly poorer WM integrity 
compared to the other genotype subgroups.  
Primary Aim 3: Examine ROI’s that significantly differ between MJ users and 
controls to determine the association between PFC gyrification and WM integrity 
and EF performance.  
 Hypothesis 3. Regions that significantly differ will be positively associated with 
performance and gyrification, such that better performance will be associated with 
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increased gyrification. In WM, a negative association with MD and performance will be 
observed, whereas a positive association with FA values and performance will be 
observed.   
II. METHODS AND MATERIALS 
PARTICIPANTS  
 Participants included 74 healthy emerging adults between the ages of 18-25 (41 
male, 33 female; 28 homozygous CC & 13 A carrying males, 19 homozygous CC & 14 A 
carrying females) from a larger parent study examining genetic moderations of drugs in 
youth (PI: Lisdahl, NIH R03 DA027457). All participants were required to be fluent in 
English and right-handed. Exclusion criteria included MRI contraindications (pregnancy, 
claustrophobia, weight over 250 lbs., ferromagnetic implants of any kind, pacemakers or 
other devices in body); history of chronic medical or neurologic illness or injury 
(meningitis, HIV, epilepsy, brain tumor, traumatic brain injury, injury resulting in >2 
minutes of unconsciousness and concussion symptoms, stroke, cerebral palsy, 
Parkinson’s disease, Huntington’s disease, high blood pressure, diabetes, consistent 
migraines); history of a learning disability; substantial complications during birth or 
premature birth; known prenatal exposure to alcohol (>4 drinks/day or >7 drinks/week) 
or illicit drugs (>10); current use of psychoactive medication; preexisting DSM-IV Axis I 
disorders independent of substance use (including major depressive disorder, bipolar 
disorder, attention deficit hyperactivity disorder, conduct disorder, social phobia, 
agoraphobia, panic disorder, generalized anxiety disorder, obsessive compulsive disorder, 
anorexia, and bulimia); and refusal to remain abstinent from all drugs and alcohol for at 
least seven days.  
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 Eligible participants were chosen if they fit into of two groups: MJ users (> 10 uses 
in past year and > 50 lifetime uses) or non-using controls (<1 past year and < 5 lifetime 
uses) and had usable MRI data. In order to minimize the impacts of comorbid alcohol use 
across both groups, heavy binge drinkers were excluded; this was assessed using past 
year Cahalan criteria and “very heavy” drinkers were excluded. Participants were also 
matched as closely as possible on age, education, ethnicity, gender, and verbal IQ. For 
the current analysis, 37 controls and 37 MJ users met proposed inclusion and exclusion 
criteria.  
PROCEDURES 
 The Institutional Review Board at the University of Cincinnati approved all 
aspects of this study and the same institution has approved ongoing analysis. Participants 
were recruited through advertisements in a local free newspaper and fliers distributed 
throughout the community and local universities. Interested participants were then 
screened by phone. After individuals provided oral informed consent, trained research 
assistants screened prospective participants over the phone for inclusion/exclusion 
criteria (mentioned above), including questions regarding past year drug use in order to 
assess matching into a particular drug use group. In addition, screeners utilized a semi-
structured interview based on DSM-IV-TR criteria for Axis I psychotic, anxiety, and 
mood disorders. Those who had positive responses to the screening questions were 
discussed in committee; if clear decisions could not be reached then they were re-
contacted and administered additional diagnostic questions based on the SCID I/P 
(determined by Dr. Lisdahl; First, Spitzer, Gibbon, & Williams, 2001). 
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 Following the phone screen, eligible participants completed either one or two 
sessions. Those with considerable drug or alcohol use completed a first session three to 
four days prior to the second session, during which they were informed of the purpose of 
the study, procedures, potential risks and benefits, and confidentiality before providing 
written informed consent. They then provided a urine sample for a drug toxicology screen 
and completed questionnaires for background and demographic information and trait-
specific psychological measures. During the second session (lasting approximately 5 to 6 
hours), abstinence was once again verified through a urine drug screen and breathalyzer 
test, psychological measures were completed, a drug use interview and 
neuropsychological battery were administered, and participants underwent a high-
resolution MRI scan. Control participants who endorsed less frequent drug use completed 
all tasks during one session (approximately 4-5 hours). Participants were paid $160 for 
two sessions or $110 for one session, reimbursed for parking, and received local drug and 
alcohol treatment resources and images of their brain. 
SCREENING INVENTORIES AND QUESTIONNAIRES 
 Biological Samples. Participants were administered a urine toxicology screen using 
the One Step Drug Screen Test, a breathalyzer test, and a pregnancy test. Those who 
tested positive for drugs and/or alcohol except MJ and nicotine were excluded, and 
pregnant women were excluded as effects of MRI scans on fetuses are unknown. 
Additionally, urine samples were sent for further analysis to provide THC-COOH (THC 
metabolite) levels to assess abstinence-related decreases from session one.  
 Demographic Information.  Participants completed a Background Questionnaire 
outlining demographic variables including age; gender; ethnicity (coded for Caucasian 
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vs. minority status); self and parents’ educations, incomes, and employments; marital 
status; number of biological and/or step/half siblings; history of medical or neurologic 
illness, psychological disorders or use of psychiatric medication, and learning disability; 
involvement in extracurricular activities or hobbies, gambling frequency, and smoker 
status.  Height and weight were also collected to calculate body mass index [BMI; 
(weight in kilograms/(height in meters)2]. 
 Drug Use. Drug use frequency was recorded to exclude for very heavy users as 
well as to control for possible variance in cognition based on amount used.  A modified 
version of the Time-Line Follow-Back (Sobell, Maisto, Sobell, & Cooper, 1979) 
interview was conducted, using memory cues such as holidays and personal events 
recorded on a calendar to measure past year drug use. Drug categories assessed were as 
follows: nicotine cigarettes, chewing tobacco/snuff/pipe, cigars/hookah, alcohol, MJ, and 
‘other’ drug use, which was a total including all of the following categories: ecstasy, 
sedatives (barbiturates, valium, Xanax, Ativan, ketamine, GHB), stimulants (cocaine, 
crack cocaine, amphetamine, and methamphetamine), hallucinogens (PCP, LSD, DMT, 
peoyote, acid, mushrooms), opioids (heroin, opium, pain pills), inhalants (paint, glue, 
household cleaners, nitrous oxide, gas), and other (anything else not mentioned). The 
participants’ drug use was measured by the number of standard units (cigarettes, hits, 
cigars for nicotine; standard drinks for alcohol; joints for MJ; tablets for ecstasy; grams 
for stimulants; number of hits or pills for inhalants, hallucinogens, and opioids; and pills 
or hits for sedatives). Participants were administered the Customary Drinking and Drug 
Use Record (CDDR), measuring lifetime and past 3-month substance use, withdrawal 
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symptoms, DSM-IV abuse and dependence criteria, and substance-related difficulties 
(Brown et al., 1998; Stewart & Brown, 1995). 
 Psychological Tests.  Participants were administered the Beck Depression 
Inventory-II (Beck, Steer, & Brown, 1996), which assess current depressive 
symptomology.  
NEUROPSYCHOLOGICAL ASSESSMENTS 
 Premorbid Intelligence. The Wechsler Abbreviated Scale of Intelligence 
(WASI) Vocabulary subtest (Wechsler, 1999) and the Wide Range Achievement Test-4th 
edition (WRAT-4) Reading subtest (Wilkinson, 2006) measured estimates of verbal 
intelligence and quality of education for group comparison purposes (see Manly, Jacobs, 
& Touradji, 2002). 
Complex Attention.  Complex attention was assessed using the total correct 
responses in the Wechsler Adult Intelligence Scale – Third Edition (WAIS-III) Letter 
Number Sequencing (LNS) and the Paced Auditory Serial Attention Test (PASAT). The 
LNS is a subscale of the WAIS-III Working Memory Index, which measures a person’s 
ability to retain numbers and letters (ranging from two to eight bits of information over 7 
separate trials) and perform a manipulation to organize the information according to a 
rule in order to provide a response (Wechsler, 1997). The PASAT is a working memory 
task in which requires participants to retain two consecutive numbers that are presented 
in a serial manner and perform a summation roughly every 2 seconds for a total of 60 
numbers (Gronwall, 1977).  Total scores on the LNS and PASAT were used for the 
current study.  
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Cognitive Inhibition. The D-KEFS Color Word Interference Test Inhibition total 
completion time assessed inhibitory ability (Delis & Kaplan, 2000).  For this task, 
participants were presented with stimuli cards containing words (red, blue or green), 
colors (blocks made of red, blue, or green), and words printed in a different color (e.g. the 
word “blue” printed in green ink).  During each of the three stimuli presentations, 
participants were asked to first read the words on the word card, name the colors on the 
color card and name the color on the mixed word/color ink card.  
GENOTYPING 
 FAAH. The FAAH variant were genotyped using the TaqMan (fluorogenic 5’ 
nuclease) assay (for example see Egan et al., 2003). The primers and the probes were 
obtained from Applied Biosystems. PCR was conducted with both primers and probes 
added in an ABI 9700 thermocycler and the endpoint results were scored using the ABI 
7900HT Sequence Detection System. 
MRI DATA ACQUISITION 
 Parameters. High-resolution anatomical images were optimized on a 4T Varian 
Unity INOVA MRI scanner at the Center for Imaging Research (CIR). T1-weighted, 3-D 
SPGR anatomical brain scan was obtained (about 30 minutes of scan time) using a 
modified driven equilibrium Fourier transform (MDEFT) sequence (FOV=25.6 cm, 
256x256x192 matrix, slice thickness=1 mm, in- plane resolution=1x1 mm, TR=13 ms, 
TE=5.3 ms, flip angle=22 ̊). Diffusion Tensor Imaging (DTI) was obtained using 12 
diffusion directions with b ≈ 600s/mm2 (FOV= 25.6 cm, 64x64x30 matrix, 
resolution=4x4x4 mm3, TR = 8,000 ms, TE = 88.8 ms, flip angle 90 ̊. Geometric and 
ghost distortion corrections were implemented using multi-echo reference scans. A 
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neuroradiologist at CIR reviewed anatomical scans and reported neurologic 
abnormalities. No participants with abnormalities were included in this sample.  
MRI PROCESSING 
 PFC Local Gyrification Analysis. Images were preprocessed using FreeSurfer’s  
3D reconstruction pipeline (http://surfer.nmr.mgh.harvard.edu; Dale, Fischl, & Sereno, 
1999). First, segmentation discerned type of tissue, resulting in segmented WM volume 
indicating location of gray-white boundary. After automatic correction for topology 
errors, a second surface was created reflecting the pial-gray boundary. Next, pial 
smoothing was applied via: [(l/r)h.pial-outer-smoothed]; which was followed by 
specifying regions of interest on the smoothed inflated surface and corresponding pial 
surface. PFC local gyrification indices (LGI) were also created using FreeSurfer software 
version 5.3 with a radius set to 20mm (Schaer et al., 2008; 2012), which quantified a ratio 
of the smoothed surface to the pial surface for each vertex and selected ROI (see Figure 
3). ROI’s were determined using an individual cortical surface-based anatomical atlas 
(Destrieux, Fischl, Dale, & Halgren, 2010). Similar to cortical thickness, each subject’s 
LGI was entered for the following ROIs: [including the PFC; dorsal lateral PFC 
(DLPFC); medial PFC (mPFC); orbital frontal PFC (OFC), which was further broken 
down into: ventral medial PFC (vmPFC) and ventral lateral PFC (vlPFC); and frontal 
pole for both right (RH) and left (LH) hemispheres]. 
 PFC Underlying WM Integrity. WM pathways were reconstructed via diffusion 
tensor imaging (DTI) using voxel based 3x3 symmetric tensor matrices differentiating 
both direction and magnitude, assuming direction was uniformly linear within each 
voxel. Fractional anistoropy (FA) was obtained through eigenvalue variance for a given 
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voxel, which determines isotropic versus anisotropic movement represented by a scalar 
value between 0 and 1. ROI-based comparison was computed through FreeSurfer version 
5.3 tractography software TRACULA (Yendiki et al., 2011), which reconstructed WM 
pathways (trac-all -path). For ROI-based analysis, participant’s DTI was registered to 
their individual T1 weighted image obtained through FreeSurfer cortical parcellation and 
subcortical segmentation (recon-all –path). 
DATA ANALYSIS 
Preliminary Analysis. All analyses were conducted using SPSS version 22.0.0. 
ANOVAs and Chi-square tests were run to examine potential demographic differences as 
well as differences in past year drug use histories between MJ users and controls by 
genotype. Variables that either differed between groups or may impact neural architecture 
were entered as covariates, such as mood symptoms (Medina et al., 2007), alcohol use 
(Medina et al., 2008) or nicotine use (Paul et al., 2008). Covariates included WRAT-4 
Reading scaled score, age, gender, ethnicity (coded for Caucasian vs. minority status), 
past year alcohol use, recent nicotine use (cotinine levels), depressive symptoms, and 
FAAH genotype (when examining MJ group status). 
Primary Analysis. AIM 1. General linear modeling (GLM) in SPSS was used to 
examine whether MJ group status, FAAH genotype, or an interaction between MJ group 
status*FAAH genotype were significantly associated with each PFC gyrification indices 
for each ROI [PFC, DLPFC, mPFC, OFC (which was further broken down into: vmPFC 
and vlPFC), and frontal pole for both RH and LH. Standard least squares multiple 
regression was used; block one included covariates (see preliminary analysis), block two 
included MJ group status, and block three included the interaction between MJ group 
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status and FAAH genotype. If the interaction (MJ*FAAH genotype) was not significant, 
only block two was interpreted. Significance was determined if p<.05.  
Primary Analysis. AIM 2.  Average FA and MD were extracted from the 
underlying WM tracts [corpus callosum forceps minor (fMinor), anterior thalamic 
radiation (ATR), and uncinate fasciculus (UNC)] in the PFC utilizing FreeSurfer ‘s 
TRACULA (Yendiki et al., 2011). Standard least squares multiple regression was used; 
block one included covariates (see preliminary analysis), block two included MJ group 
status, and block three included the interaction between MJ group status and FAAH 
genotype. If the interaction (MJ*FAAH genotype) was not significant, only block two 
was interpreted. Significance was determined if p<.05.  
Primary Analysis. AIM 3: Pearson correlations were run between cognitive 
performance (complex attention and cognitive inhibition; see Price et al., under review) 
in MJ users and both gyrification and WM variables that significantly differed between 
MJ users and controls. Significance was determined if p<.05.  
III. RESULTS 
DEMOGRAPHIC & MOOD INFORMATION 
 ANOVAs and chi-squares tested whether MJ users and non-using controls 
differed in demographic variables (see Table 1). Significant differences were found 
between MJ users and controls in BDI-II depressive symptoms with MJ users reporting 
more than controls [F(1,72)=4.10, p=.05]. MJ users and controls did not differ in 
ethnicity [64.9% Caucasian for MJ users and controls, x2(4)3.43, p=.49], gender 
[x2(1)2.68, p=.10], past year Cahalan criteria [x2(5)4.62, p=.46], age [F(1,72)=.41, 
  
 
22 
p=.52], WRAT-4 Reading standard score [F(1,72)=.36, p=.55], education [F(1,72)=1.43, 
p=.24], annual income [F(1,72)=.09, p=.76], or body mass index [F(1,71)=.08, p=.77].   
 ANOVAs and chi-squares tested whether FAAH genotype differences between 
C/C carriers and A carriers (see Table 1). Significant differences were found between 
C/C and A carriers in ethnicity (76.6% of C/C carriers were Caucasian and 44.4% of A 
carriers were Caucasian) [x2(4)12.56, p=.01], age [F(1,72)=5.85, p=.02], WRAT-4 
Reading standard score [F(1,72)=6.6, p=.01], and BDI-II depressive symptoms 
[F(1,72)=6.23, p=.02]. No differences were found between genotypes in gender [x2(1).91, 
p=.34], education [F(1,72)=.09, p=.77], income [F(1,72)=2.2, p=.14], or body mass index 
[F(1,71)=.08, p=.78].  
------------------------- 
Insert Table 1 Here 
------------------------- 
ALLELE FREQUENCIES 
 FAAH allele frequencies for 74 subjects were: 47 C/C carriers status and 27 A 
carriers status (see Table 1). A marginal difference was found between MJ users and 
controls in FAAH genotype [63% of MJ users were A carriers and 37.4% of controls were 
A carriers, [x2(1)2.86, p=.09].  
DRUG USE INFORMATION 
 As expected, MJ users differed from controls in lifetime nicotine use [x2(6)22.75, 
p=.001], lifetime alcohol use x2(5)13.89, p=.02], lifetime MJ use x2(5)63.41, p=.001], 
lifetime other drug use (although this was limited) [x2(4)34.97, p=.001], cotinine level 
[F(1,71)=20.98, p=.001], past year nicotine use [F(1,72)=8.03, p=.006], past year alcohol 
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use [F(1,72)=6.37, p=.014], and past year MJ use [F(1,72)=15.94, p=.001] (see Table 1). 
No difference between past year other drug use existed between MJ users and controls 
[F(1,72)=3.49, p=.07].  
C/C carriers and A carriers did not differ in past year Cahalan criteria [x2(5)8.94, 
p=.11], lifetime nicotine use [x2(6)4.56, p=.60], lifetime alcohol [use x2(5)5.72, p=.34], 
lifetime MJ use [x2(5)3.06, p=.69], lifetime other drug use [x2(4)2.59, p=.63], cotinine 
level, [F(1,71)=2.58, p=.11], past year nicotine use [F(1,72)=.95, p=.33], past year 
alcohol use [F(1,72)=.003, p=.96], past year MJ use [F(1,72)=.42, p=.52], or past year 
other drug use [F(1,72)=1.32, p=.26] (see Table 1). 
MULTIVARIATE RELATIONSHIPS  
Aim 1 Regression Analysis: Gyrification: MJ Group Status. After controlling for 
WRAT-4 Reading scaled score, age, gender, ethnicity, past year alcohol use, cotinine 
levels, depressive symptoms, and FAAH genotype, MJ users demonstrated significantly 
increased gyrification in the LH DLPFC [t (63) = 3.0, beta=.40, p=.004] in comparison to 
controls (see Table 2). In contrast, MJ users demonstrated reduced gyrification in 
bilateral OFC (RH: [t (63) =-2.3, beta=-.32, p=.02] and LH: [t (62) = -1.97, beta=-.28, 
p=.05]),  specifically, bilateral vmPFC (RH: [t (63) = -4.1, beta=-.54, p<.001] and LH: [t 
(63) = -4.1, beta=-.55, p<.001]); bilateral mPFC (RH: [t (63) = -3.6, beta=-.48, p=.001] 
and LH: [t (63) = -3.8, beta=-.51, p<.001]); and bilateral frontal poles (RH: [t (63) = -2.3, 
beta=-.31, p=.02]; LH: [t (63) = -2.998, beta=-.43, p=.004]). FAAH Genotype. FAAH 
genotype significantly predicted local gyrification index in the LH DLPFC [t (63) =  
-1.998, beta=-.25, p=.05], with C/C genotypes demonstrating increased gyrification 
compared to A carriers. MJ*FAAH Interaction. FAAH genotype interacted with MJ 
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group status to significantly predict gyrification in the LH OFC [t (62) = -2.1, beta=-.24, 
p=.04] in that the MJ users with CC genotype had increased gyrification while A carriers 
had decreased, the controls demonstrated no significant difference in gyrification 
between genotypes (see Figure 4). Covariates. Increased depressive symptoms predicted 
decreased gyrification in the LH DLPFC [t (63) = -3.1, beta=-.37, p=.003]. Gender 
predicted gyrification in bilateral PFC RH: [t (63) = -2.9, beta=-.37, p=.005] and LH: [t 
(63) = -3.6, beta=-.43, p=.001]; bilateral OFC RH: [t (63) = -2.7, beta=-.33, p=.009] and 
LH: [t (63) = -3.1, beta=-.39, p=.003], specifically bilateral vlPFC RH: [t (63) = -2.2, 
beta=-.28, p=.03] and LH: [t (63) = -2.3, beta=-.29, p=.03]; bilateral mPFC RH: [t (63) = 
-3.3, beta=-.38, p=.002] and LH: [t (63) = -2.4, beta=-.28, p=.02]; bilateral vmPFC RH: 
[t (63) = -3.5, beta=-.41, p=.001] and LH: [t (63) = -2.3, beta=-.28, p=.02]; and bilateral 
frontal pole RH: [t (63) = -2.95, beta=-.35, p=.004] and LH: [t (63) = -2.1, beta=-.27, 
p=.04], such that women demonstrated reduced gyrification in each area mentioned. 
Ethnicity minority status predicted gyrification in the LH PFC [t (63) = -2.0, beta=-.25, 
p=.05], such that reduced gyrification was found for ethnic minorities compared to 
Caucasians.  Age predicted gyrification in OFC (LH) [t (62) = -3.0, beta=-.37, p=.004], 
such that older age was associated with decreased gyrfication in this region. 
------------------------- 
Insert Table 2 Here 
------------------------- 
Aim 2 Regression Analysis: White Matter Integrity: MJ Group Status. After 
controlling for WRAT-4 Reading scaled score, age, gender, ethnicity (coded for 
Caucasian vs. minority status), past year alcohol use, cotinine levels, depressive 
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symptoms, and FAAH genotype, MJ users demonstrated increased MD in fminor [t (62) = 
1.96, beta=.27, p=.05], bilateral UNC (RH: [t (62) = 2.3, beta=.32, p=.03] and LH: [t 
(62) = 2.2, beta=.31, p=.03]) (see Table 3). FAAH Genotype. FAAH genotype did not 
demonstrate any significant contributions. MJ*FAAH Interaction. FAAH genotype 
interacted with MJ Group status to significantly predict FA in fMinor [t (61) = 2.1, 
beta=.26, p=.04] and LH ATR [t (61) = 3.1, beta=.36, p=.003]. In the fMinor MJ users 
with C/C genotype demonstrated reduced integrity (FA), whereas the A carrier controls 
demonstrated reduced integrity (FA) (see Figure 5). In LH ATR, MJ users with C/C  
genotype demonstrated reduced integrity (FA) (see Figure 6).  
------------------------------------ 
Insert Figures 5 & 6 Here 
------------------------------------ 
Covariates. WRAT-4 Reading Standard Score predicted MD in the RH ATR [t (62) 
= -2.1, beta=-.28, p=.04], MD in the LH ATR [t (62) = -2.9, beta=-.37, p=.005], such 
that higher scores were associated with decreased MD. Ethnicity predicted MD in the RH 
ATR [t (62) = -2.3, beta=-.28, p=.02], such that ethnic minorities demonstrated reduced 
MD compared to Caucasians. Cotinine levels predicted decreased FA in the RH ATR [t 
(62) = -1.97, beta=-.24, p=.05], such that higher cotinine levels were associated with a 
decrease in FA. Increased depressive symptoms predicted increased MD in the LH ATR 
[t (62) = 2.8, beta=.34, p=.006]. See Table 3 for mean DTI values by group. 
------------------------- 
Insert Table 3 Here 
------------------------- 
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Aim 3 Correlation Analysis: Brain-Behavior Relationships:  
 MJ Group. Pearson r correlation revealed a positive correlation with gyrification 
and LNS performance in the RH mPFC [r=.51, n=37, p=.001], RH vmPFC [r=.41, n=37, 
p=.01], and RH frontal pole [r=.45, n=37, p=.005], with high degree of gyrification 
associated with better performance. Additionally, there was a negative correlation with 
gyrification and color-word inhibition completion time in the LH vmPFC [r=-.32, n=37, 
p=.05], with increased gyrification associated with faster response times.  
 Within the WM, a positive correlation was observed in MD and PASAT total 
correct in the RH UNC [r=.38, n=37, p=.02], with higher MD associated with better  
performance time. Overall, both increased gyrification and increased MD were associated 
with improved working memory and faster response time on an inhibitory task.  
 Controls. Positive correlations were found with gyrification and complex attention 
in bilateral OFC: RH /PASAT: [r=.35, n=36, p=.04], RH /LNS: [r=.34, n=37, p=.04], and 
LH/PASAT: [r=.36, n=36, p=.03], with increased gyrification associated with better 
performance. A positive correlation was found between gyrification and PASAT correct 
in the RH frontal pole [r=.35, n=36, p=.04], with greater gyrification associated with 
better performance. No significant relationships were demonstrated for controls in WM 
tracts examined (fMinor and bilateral UNC). See Table 4 for mean neuropsychological 
performances by group and genotype. 
------------------------- 
Insert Table 4 Here 
------------------------- 
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DISCUSSION  
 This study examined the relationship between the FAAH genotype, MJ group status, 
and brain structure (gyrification and WM integrity) in a sample of 18-25 year old 
emerging adults with and without chronic MJ use. Follow-up analyses assessed the brain-
behavior relationships between significant structural findings and executive abilities, 
including complex attention and inhibition. Consistent with the predicted hypotheses, MJ 
users had reduced gyrification and poorer WM integrity in several PFC regions in 
comparison to matched controls. We also found that FAAH genotype mediated the impact 
of MJ use on structural characteristics. The primary results revealed significantly reduced 
gyrification in MJ users in comparison to controls in several PFC regions (bilateral OFC, 
bilateral mPFC and bilateral frontal poles), while one region showed an opposite 
relationship, with increased gyrification for MJ users (LH DLPFC). WM findings 
indicate an increase in MD for MJ users in the corpus callosum fMinor and bilateral 
UNC, suggesting poorer microstructural integrity in MJ using young adults. FAAH 
genotype findings indicate that A carriers, including both control and MJ users, had 
reduced gyrification in the LH DLPFC. MJ users with A genotype demonstrated reduced 
gyrification in the LH OFC; however, MJ users that were C/C carriers had reduced WM 
integrity in the fMinor and LH ATR. In controls, A carriers demonstrated reduced WM 
integrity in the fMinor. Therefore, the current study found abnormal gray matter and WM 
structure in emerging adult MJ users, and reduced gyrification was associated with poorer 
executive functioning, specifically complex attention and inhibition.  
 We found decreased gyrification in the MJ users in several PFC regions. This is 
consistent with prior research demonstrating aberrant PFC characteristics in MJ using 
  
 
28 
youth (Churchwell et al., 2010; Gruber et al., 2011; Lopez-Larson et al., 2011; Medina et 
al., 2009; Price et al., under review; Wilson et al., 2000). Findings were also consistent 
with Mata and colleagues (2010), who found reduced sulcal concavity in frontal lobes of 
young adult MJ users in comparison to non-users. We found greater gyrification in the 
DLPFC LH of MJ users. This particular PFC region is the last to develop (Gogtay et al., 
2004), and the mean age of this sample was 21.4. Thus, MJ users may have not 
undergone maturation in this region and evidence suggests asymmetries in maturation 
rates (see Toga & Thompson, 2003).  Though the mechanisms driving gyrification are 
unclear, whether predominant influence is attributed to amount of connectivity and 
tension (Van Essen, 1997) or differential expansion of cortical layers (Richman et al., 
1975; Ronan et al., 2013), both perspectives may be influenced by interruptions in 
myelination refinement, which may be related to poorer WM integrity in our sample (see 
WM section). Twin studies reveal that environmental stimuli or non-genetic influences 
greatly influence gyrification patterns (Bartley, Jones, & Weinberger, 1997), particularly 
within the PFC (Hasan et al., 2011). As PFC changes in sulcal and gyral complexity 
continue to extend into late adolescents (Blanton et al., 2001), environmental influences, 
including regular MJ use, during this developmental period may be detrimental to brain 
development and functioning (Becker et al., 2010; Gruber, Dahlgren, Sagar, Gönenc & 
Killgore 2012; Jager et al., 2010; see Lisdahl et al., 2013; Meier et al., 2012). During 
adolescence, neurotrophins involved in neuronal growth and pruning, play a key role in 
nervous system maturation (see Reichardt, 2006) and may be reduced in adult MJ users 
(Angelucci et al., 2008; D’Souza, Pittman, Perry, & Simen 2009). The impact of MJ use 
on in-vivo adolescent neurotrophin levels is unknown; however, divergent inter-cortical 
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growth rates and changes in connectivity are thought to impact gyrification patterns (Van 
Essen, 1997; Richman et al., 1975; White & Hilgetag, 2008; Ronan et al., 2013), which 
may be interrupted with adolescent MJ use increasing risk factors. For example, 
neurotrophic transcription may be altered as a result of physical activity (see Gomez-
Pinilla, 2008; Trejo, Llorens-Martin, & Torres-Alemain, 2008) and adolescent MJ use 
has demonstrated an inverse relationship with physical activity (Winnail & Valois, 1995).   
 Among gray matter regions where MJ users differed from controls in gyrification 
indices [LH DLPFC, bilateral OFC, bilateral vmPFC, bilateral mPFC, and bilateral 
frontal poles], increased gyrification in right hemisphere: mPFC, vmPFC and frontal pole 
was associated with better performance on LNS total scores in MJ users. In controls, 
increased OFC gyrification and RH frontal pole was associated with better complex 
attention scores. The OFC has an important role in inhibiting reward-driven behavior and 
may be compromised in addicted individuals (Lubman, Yucel, & Pantelis, 2004). 
Ultimately, for both groups, increased gyrification was associated with better 
performance scores suggesting that functional benefit is gained with greater gyrification. 
Phylogeny of gyrification exposes an increase in surface area with minimal increases in 
cortical thickness (Welker, 1990), which serves to reduce volume expansion and 
maximize computational potential (see White et al., 2010).  
 In WM, we found increases in MD for MJ users in the fMinor and bilateral UNC, 
suggesting poorer microstructural integrity in MJ using young adults compared to non-
users. This is consistent with previous research indicating WM degradation in young MJ 
users (Arnone et al., 2008; Bava et al., 2009; Abou-Saleh, 2010; Yücel et al., 2010; Clark 
et al., 2012; Zalesky et al., 2012) and in a group with comorbid alcohol use (Ashtari et 
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al., 2009). Additionally, the UNC may play an integral role in emotion regulation, as it 
serves to connect the amygdala with the PFC (see Stuss, 2002). Previous research reflects 
that greater FA in the UNC predicted lessened amygdala activation in adolescents, while 
increased amygdala activation to sad faces was associated with greater internalization of 
symptoms (Swartz, Carrasco, Wiggins, Thomason, & Monk, 2014), suggesting potential 
difficulties with emotional regulation. Thus, reduced WM integrity in fronto-limbic 
regions of MJ users, as seen with this study, may indicate disruption of WM refinement 
impacting executive control and affective regulation.  Further, here we found evidence 
that supports a relationship between surface geometry and underlying WM integrity. MJ 
users demonstrated specific reductions in medial and ventral aspects of the PFC in 
addition to decreased WM integrity tracts that project directly to these cortical regions, 
offering additional support for the potential role of WM connectivity on gyrification (Van 
Essen, 1997). 
 There has been conflicting evidence relating FAAH genotype to behavioral 
outcomes (Tyndale et al., 2007; Filbey et a., 2010; Haughey et al., 2008; Schatch et a., 
2009; Conzelmann et al., 2012; Hariri et al., 2009), however our study suggests that 
genotype may impact gray matter and WM differently. We found reduced gyrification for 
FAAH A carriers compared to C/C carriers in the left hemisphere DLPFC.  We also found 
a significant MJ by FAAH interaction such that reduced gyrification was found in A 
carrying MJ users for the left hemisphere OFC. Genotype did not affect gyrification in 
this region for controls. Within WM, a significant interaction between FAAH genotype 
and MJ group status exposed relationships with FA measures of WM cohesion in fMinor 
and left hemisphere ATR. Reduced fMinor integrity in MJ users was observed in C/C 
  
 
31 
carriers; however, we found an opposite relationship in controls where A carriers had 
reduced WM integrity in this tract. We also found C/C carrying MJ users demonstrated 
reduced WM integrity in the left hemisphere of the ATR. Genotype did not impact the 
impact of WM integrity in the LH ATR for controls.      
 In youth, C/C genotype may increase risk associated with MJ use (Haughey et al., 
2008; Schatch et a., 2009). Chronic MJ use may cause functional PFC changes in ECS 
(Hirvonen et al., 2012); for example, adolescent MJ users demonstrate reduced GLU 
levels within the PFC (Prescot, Locatelli, Renshaw, & Yurgelun-Todd, 2011). Reduced 
GLU may weaken neurons’ ability to retain synaptic connections, as evidenced in 
animals (Won Chan, Hill, Zito, 2013). Further, animal models suggest that THC exposure 
during adolescence may increase abnormalities in several proteins related to cellular 
structure and oxidative state compared to adulthood (Quinn et al., 2008) and changes in 
CB1/G-protein coupling and CB1 receptor densities extending into adulthood (Rubino et 
al., 2008), which may underlie performance deficits and behavioral changes depending 
on the developmental stage of exposure (Schneider & Koch, 2003; Schneider & Koch, 
2005; O’Shea, Singh, McGregor & Mallet, 2004). Therefore, in MJ users, the C/C 
genotype, associated with lower AEA (Sipe et al., 2010), may confer additional risk for 
neurocognitive consequences. However, the current results are mixed (MJ-using A 
carriers demonstrated reduced gyrification in DLPFC and OFC while C/C genotype was 
associated with poorer fMinor and ATR WM integrity). Therefore, additional research is 
needed to help clarify the relationship between FAAH genotype, MJ exposure and brain 
structure in youth.  
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 In non-MJ using youth, A carrier status, which is associated with increased AEA 
levels (Sipe et al., 2010) may be detrimental to underlying structural complexity. CB1 
receptors undergo somatodendritic recycling and trafficking targeting axons (Leterrier et 
al., 2006), and agonist-induced desensitization may lower CB1 receptor mobility 
(Mikasova, Groc, Choquet, & Manzoni, 2008). Therefore, chronic MJ use during youth 
may interrupt this process. ECS may also play a key role in myelination, which may be 
regulated via communication between oligodendrocytes and neurons (gray matter) 
(Simons & Trajkovic, 2006). We found A carrying controls had reduced WM integrity, 
the opposite of MJ-users. Increased cannabinoid signaling may enhance myelination in 
populations suffering myelination loss, as evidenced by animal models (Webb, Luo, Ying 
Ma, & Tham, 2008); however, in young adult controls enhanced ECS may be associated 
with poorer WM cohesiveness. In sum, aberrant ECS during emerging adulthood either 
through MJ use or genotype, may be associated with poorer brain characteristics and 
FAAH genotype may moderate the impact of adolescent MJ use on brain development 
and be tissue specific.   
------------------------- 
Insert Figure 7 Here 
------------------------- 
 Among WM regions that differed between MJ users and controls [fMinor and 
bilateral UNC], there was one significant relationship that found reduced integrity in the 
right hemisphere UNC to be associated with increased performance on a working 
memory task. Though typical performance data suggests that increases in WM integrity 
are associated with improved performance (Tamnes et al., 2011), we found this untrue for 
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one tract in MJ users only. This finding may be related to reduced affective interference 
during a demanding and stress-provoking task. Additionally, in controls, WM integrity 
was not associated with better or worse performance.  
 Chronic MJ use during adolescence and emerging adulthood appears to have 
negative influence on brain structure. Young adult users reflect demonstrate aberrant 
brain characteristics that are consistent with neuropsychological (Lisdahl & Price, 2012). 
Extensive cortical remodeling is occurring during adolescence (see Crews, He, & Hodge, 
2007), and the current study found that MJ use during this time was associated with 
reduced PFC gyrification and poorer underlying WM integrity. ECS appears to be 
important for brain maturation and reliance on CB1 binding may increase in adulthood 
(Verdurand et al., 2011). Consequently, chronic emerging adult MJ use may interfere 
with brain maturation. 
 Limitations. Alcohol and MJ remain highly comorbid (Johnston et al., 2011b). 
Although the current study statistically controlled for alcohol and excluded “very heavy” 
drinkers (according to Calahan criteria), it is possible that some of the findings are 
associated with combined or simultaneous MJ and alcohol use. For example, WM 
integrity differences have been found in samples combining MJ and alcohol use may 
impact WM tracts in adolescents and young adults (Jacobus, Squeglia, Infante, Bava, & 
Tapert, 2013; Bava, Jacobus, Thayer, & Tapert, 2013; Jacobus, Squeglia, Bava, & Tapert, 
2013; Bava, et al., 2010; Bava et al., 2009), though combined MJ and alcohol use may be 
less detrimental on WM integrity than binge-drinking alone (Jacobus et al., 2009). Future 
studies may want to investigate differences in simultaneous MJ and alcohol use versus 
separate occasion uses of each substance.  
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Another potential limitation of the current study is that it is difficult to determine 
what results are due to premorbid differences that may have been present prior to MJ 
exposure. For example, one longitudinal study suggests that smaller OFC predicts MJ use 
during adolescence, although this sample included current or past psychiatric diagnoses 
(Cheetham et al., 2012). Conversely, prospective longitudinal findings have demonstrated 
a decline in intellectual and neuropsychological functioning among adolescent-onset 
(before age 18) even after cessation of 1 or more years (Meier et al., 2012), indicating 
that early MJ use may affect the developing brain such that individuals never achieve 
their estimated intellectual performance even with sustained abstinence. This aligns with 
marked neuronal changes in animal models when exposure occurs during adolescence 
(Schneider & Koch, 2003; O’Shea et al., 2004; Cha, White, Kuhn, Wilson, & 
Swartzwelder, 2006; Quinn et al., 2008; Rubino, & Parolaro, 2008). In general, some 
recovery in functioning may be experienced with discontinued use (Schwartz et al., 1989; 
Fried et al., 2005; Hanson et al., 2010; Tait et al., 2011); however, full IQ potential may 
not be reached with adult abstinence (Meier et al., 2012).  
Conclusions. Overall, this study demonstrates that regular MJ use impacts brain 
structure in adolescents and young adults. Specifically, we found general decreases in 
gray matter gyrification and decreased WM integrity in adolescent MJ users, which was 
moderated in some regions by FAAH genotype. Therefore, it is an important public health 
priority to delay the onset of regular MJ use until neuronal maturation has been reached 
(see Lisdahl et al., 2013).  
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Figure 1: Study Design (Aims 1 & 2) –Impact of MJ, FAAH Genotype, and MJ x FAAH 
on Gyrification and WM Integrity).  
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Figure 2: Study Design (Aim 3) –Correlation of Significantly Divergent Regions 
Between MJ Users and Controls and Executive Functioning Performance.  
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Figure 3: Gyrification Analysis Pipeline.  
 
 
 
Image obtained from Schaer and colleagues (2012). NOTE: For this study, LGI was 
obtained and analyzed using SPSS and did not use FreeSurfer’s statistical program. 
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Figure 4: Mean Gyrification for OFC (LH) varies by FAAH genotype in MJ users.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
39 
 
Figure 5: Mean FA for fMinor varies by group and FAAH genotype.  
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Figure 6: Mean FA for ATR (LH) varies by FAAH genotype in MJ users.  
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Figure 7. Theoretical Influence of ECS on Brain Complexity. 
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Table 1. Demographic & Substance Use Information According to Group & Genotype. 
 
 
Notes:* p<.05; ** p<.01. 
 
 
 
 
 MJ Users 
(n = 37) 
Controls 
(n = 37) 
FAAH  
Carrier of A 
 (n = 27) 
FAAH 
C/C  
(n = 47) 
Age 21.4  
(2.42) 
[18 – 25] 
21.1  
(2.3) 
[18 – 25] 
22.07  
(2.25)* 
[18 – 25] 
20.74 
(2.29)* 
[18 – 25] 
% Female 35.1% 54.1% 51.9% 40.4% 
% Caucasian 64.9% 64.9% 44.4%** 76.6% ** 
FAAH genotype C/C% 42.6% 57.4%   
WRAT-4 Reading  
Standard Score 
 
102.92  
(15.66) 
[73 – 134] 
101.08  
(9.97)  
[81 – 120] 
97.04 
(10.05)** 
[80 – 120] 
104.85 
(13.83)** 
[73 – 134] 
Education 13.32 (1.97) 
[9–19] 
13.84 (1.71) 
[11 – 18] 
13.67 (2.08) 
[9 – 19] 
13.53 (1.73) 
[11 – 18] 
Beck Depression  
Inventory Total-2 
5.11 
(3.75)* 
[0 – 17] 
 3.43  
(3.35)* 
[0 – 14] 
 2.93  
(2.46)* 
[0 – 8] 
 5.04 
(3.98)* 
[0 – 17] 
Past year nicotine use 1696.92 
(2459.63)** 
[0 – 7350] 
 448.35 
(1065.31)** 
[0 – 3680] 
 775.37 
(1182.83) 
[0 – 3680] 
 1243.40 
(2318.90)  
[0 – 7350] 
Cotinine levels 3.83  
(2.4)** 
[0 – 6] 
1.41 
(2.11)** 
[0 – 6] 
 3.22  
(2.53) 
[0 – 6] 
 2.24  
(2.53) 
[0 – 6] 
Past year alcohol  
use 
277.73  
(363.56)** 
[0 – 1724] 
 
 111.43 
(168.67)** 
[0 – 878] 
 192.26 
(331.80) 
[2 – 1724] 
 195.91 
(273.13) 
[0 – 1238] 
Past year  
marijuana use 
 490.62  
(746.17)** 
[4 – 3895] 
.84 
(2.23)** 
[0 – 10] 
303.19 
(445.17) 
[0 – 1662] 
212.72  
(645.87) 
[0 – 3895] 
Past year other  
drug use 
8.92 
(28.70)  
[0 – 171] 
.12 
(.52)  
[0 – 3] 
.89  
(2.4) 
[0 – 12] 
6.6  
(25.7) 
[0 – 171] 
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Table 2. Descriptive Statistics of Local Gyrification Indices According to Group.  
 
 Marijuana Users 
(n = 37) 
Controls 
(n = 37) 
LGI M (SD) Range M (SD) Range 
Prefrontal Cortex (RH) 
 
2.94 (0.23) 2.63-3.94 3.03 (0.50) 2.48-5.24 
Prefrontal Cortex (LH) 2.89 (0.18) 2.56-3.36 2.89 (0.17) 2.47-3.22 
DLPFC (RH)  3.58 (0.32) 2.61-4.80 3.44 (0.65) 2.46-6.06 
DLPFC (LH) 3.58 (0.30)** 2.69-4.23 3.32 (0.41)** 2.62-4.05 
OFC (RH) 2.64 (0.26)* 2.02-3.54 2.80 (0.43)* 2.39-4.80 
OFC (LH) 2.58 (0.18)* 2.17-2.93 2.66 (0.21)* 2.39-3.47 
mPFC (RH) 2.19 (0.21)** 1.93-2.91 2.55 (0.61)** 1.85-4.58 
mPFC (LH) 2.09 (0.19)** 1.82-2.84 2.37 (0.43)** 1.79-3.33 
vmPFC (RH) 2.11 (0.23)** 1.72-2.98 2.45 (0.54)** 1.80-4.20 
vmPFC(LH) 1.99 (0.17)** 1.76-2.67 2.31 (0.47)** 1.83-3.85 
vlPFC (RH) 2.79 (0.28) 2.11-3.65 2.91 (0.46) 2.47-4.93 
vlPFC (LH) 2.79 (0.22) 2.34-3.20 2.79 (0.19) 2.41-3.32 
Frontal Pole (RH) 2.23 (0.18)* 1.92-2.87 2.42 (0.44)* 1.89-3.81 
Frontal Pole (LH) 2.07 (0.16)** 1.74-2.47 2.23 (0.29)** 1.88-2.91 
 
Notes: * p<.05; ** p<.01. 
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Table 3. Descriptive Statistics of Diffusion Tensor Imaging Values According by Group.  
 
 Marijuana Users 
(n = 37) 
Controls 
(n = 37) 
DTI M  (SD) Range 
M  
(SD) Range 
ATR- MD (RH) 0.0008  (0.00007) 0.0007-0.001 
0.0008  
(0.0001) 0.0003-0.0009 
ATR- FA (RH) 0.41 (0.06) 
 
( 
0.26-0.50 0.44 (0.05) 0.28-0.55 
ATR- MD (LH) 0.0008  (0.00007) 0.0007-0.001 
0.0008  
(0.0001) 0.0004-0.001 
ATR- FA (LH) 0.41 (0.07) 0.27-0.53 0.44 (0.049) 0.29-0.57 
UNC- MD (RH) 0.0009  (0.00008)* 0.0007-0.001 
0.0008  
(0.0001)* 0.0003-0.001 
UNC- FA (RH) 0.38 (0.07) 0.20-0.51 0.40 (0.06) 0.23-0.52 
UNC- MD (LH) 0.0009  (0.0001)* 0.0008-0.001 
0.0008  
(0.0001)* 0.0004-0.001 
UNC- FA (LH) 0.36 (0.07) 0.19-0.48 0.40 (0.06) 0.24-0.50 
fMinor- MD 0.0009  (0.0001)* 0.0007-0.001 
0.0008  
(0.0001)* 0.0004-0.001 
fMinor- FA 0.48 (0.09) 0.27-0.62 0.51 (0.08) 0.28-0.66 
 
Notes: ATR-Anterior Thalamic Radiation; UNC- Uncinate Fasciculus; fMinor- Corpus Callosum Forceps 
Minor; * p<.05; ** p<.01 
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Table 4. Descriptive Statistics of Neuropsychological Performance by Group & Genotype.  
 
 Neuropsychological Performance 
Group LNS total 
M (SD) 
[range] 
 
PASAT total 
M (SD) 
[range] 
 
D-KEFS Color-Word time 
M (SD) 
[range] 
 
Marijuana Users 11.68 (2.82) 
[6-16] 
(n=37) 
36.7 (10.1) 
[15-57] 
(n=37) 
45.8 (9.77) 
[27-70] 
(n=37) 
Controls 11.7 (2.72) 
8-18 
(n=37) 
35.6 (12.9) 
11-59 
(n=36) 
47.5 (9.6) 
27-73 
(n=37) 
 
 Neuropsychological Performance 
FAAH genotype LNS total 
M (SD) 
[range] 
 
PASAT total 
M (SD) 
[range] 
 
D-KEFS Color-Word time 
M (SD) 
[range] 
 
A carriers  11 (2.11)  
[7-15] 
(n=27) 
34.4 (12.5) 
[11-57] 
(n=26) 
50.3 (10.4) 
[34-70] 
(n=27) 
C/C carriers 12.1 (3.00) 
[6-18] 
(n=47) 
37.1 (10.9) 
[15-59] 
(n=47) 
44.6 (8.7) 
[27-43] 
(n=47) 
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